Purpose: This study aimed to evaluate the safety and efficacy of gemcitabine and cisplatin (GP) regimen in combination with immune checkpoint inhibitor sintilimab as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC) patients and the feasibility of the following selective bladder sparing surgery. Materials and Methods: Patients with histopathologically confirmed urothelial carcinoma without distant metastases (T2-4a, N ≤ 1, M0, American Joint Committee of Cancer 8th) and with adequate organ function will be enrolled. The therapeutic regimen was sintilimab 200 mg once on day 8, gemcitabine 1,000 mg/m2 and cisplatin 35 mg/m2 once on days 1 and 8, every 21 days for four cycles. The primary endpoint was pathologic complete response (pCR, pT0N0) rate. The secondary end points were ypT < 2 rate, R0 resection rate, event-free survival, and safety. Results: From May 4, 2020, to May 20, 2023, 55 patients were enrolled. Forty-six patients were evaluated for efficacy. Among the 42 patients who underwent surgery, 16 patients (38.0%) achieved pCR. Thirty-three patients (78.6%) achieved pT < 2. With a median follow-up of 15.7 months, the 1-year event-free survival was 91.3%. Notwithstanding the poor pathological baseline characteristic of a high T3-T4a proportion (39.1%), a promising bladder preservation (including 22 patients transurethral resection of bladder tumor, 5 patients partial cystectomy, and 4 surveillances) rate was achieved (67.4%). The most common grade ≥ 3 treatment-related adverse events was neutropenia (n=15, 27.3%), which was related to chemotherapy. There were no grade 3 immune-related adverse events. Conclusion Neoadjuvant GP plus sintilimab is a promising regimen for MIBC patients, with relatively high pT < 2 rate and triggering the emerging roles for the multi-disciplinary team decision-making for bladder sparing surgery.

ObjectiveTo establish a highly specific and sensitive triplex TaqMan quantitative PCR method for the detection of mouse hepatitis virus (MHV), mouse parvovirus (MPV), and reovirus type 3 (Reo-3) in laboratory mice. MethodsRecombinant plasmid standards were constructed using conserved genomic regions of the three target viruses. Specific primers and probes were designed, and a triplex TaqMan quantitative PCR (qPCR) system was optimized through preliminary experiments. Sensitivity was evaluated using 10-fold serial dilutions (10¹-10⁷ copies/μL). Intra- and inter-assay repeatability were assessed via reproducibility experiments. ResultsA strong linear correlation (R ²>0.99) was observed between copy number and Ct value at template concentrations of 10²-10⁷ copies/μL. Intra-assay and inter-assay coefficients of variation (CV) were both below 5%. No cross-reactivity was observed with mouse cytomegalovirus (MCMV), vesicular stomatitis virus (VSV), Sendai virus (SeV), or pneumonia virus of mice (PVM). ConclusionThe triplex TaqMan quantitative PCR method established in this study has high sensitivity, good repeatability, and strong specificity. It enables the rapid, specific, and sensitive detection of MHV, MPV, and Reo-3, allows the simultaneous detection of multiple pathogens in a single tube, and can be applied to the detection of clinical samples from laboratory animals and to epidemiological investigations, thereby providing effective scientific and technological support for the prevention and control of viral infection and the interruption of transmission.

Objective:To construct a communication skills assessment scale for newly employed nurses, verify the reliability and validity of the scale in a simulated setting, and develop and construct an effective and structured assessment tool for the communication skills of newly employed nurses.Methods:The Chinese version of the Liverpool Communication Skills Assessment Scale was modified and two rounds of expert consultation were conducted to construct the communication skills assessment scale for newly employed nurses. A total of 194 newly employed nurses at a tertiary hospital between 2024 and 2025 were selected using convenience sampling. Data were collected using a teacher-based evaluation method during simulated communication scenarios. The performance of the nurses was scored, and the reliability and validity of the scale were analyzed.Results:The final version of the scale consisted of 4 dimensions and 11 items, and can be used in both workplace-based and simulation-based evaluations. The expert authority coefficients of both rounds were greater than 0.70. The Kendall's W coordination coefficients for the two rounds of consultation were 0.278 and 0.309 for workplace-based evaluations and 0.256 and 0.295 for simulation-based evaluations. The coefficients of variation for the 11 items in both application scenarios were <0.250. The total Cronbach's alpha coefficient of the scale was 0.805 and the total split-half reliability coefficient was 0.814. In the two application scenarios, the item-level content validity index ranged from 0.769 to 1.000 (all >0.750). The scale-level content validity index was 0.916 and 0.909 (>0.900), respectively, in the workplace-based and simulation-based evaluations. The exploratory factor analysis extracted a total of four common factors, with a cumulative variance contribution of 69.09%, and all item loadings on their corresponding factors exceeded 0.500. Conclusions:The communication skills assessment scale for newly employed nurses has moderate and validated content and number of items. The scale demonstrates high reliability and validity in simulation-based evaluations, and can be used as an effective tool for assessing the communication skills of newly employed nurses.

Objective:To systematically evaluate the efficacy, patient-reported outcomes (PROs) and safety of hyaluronic acid (HA) fillers and collagen stimulators (PCL/PLLA) for various facial aesthetic indications.Methods:This study focused on facial fillers approved and widely used in China, including HA fillers such as Juvéderm?, Restylane?, Belotero?, Fillmed?, and PCL/PLLA such as Ellansé?, L?viselle?, and CureWhite?. A systematic literature search was conducted across both English and Chinese databases, including PubMed, Cochrane Library, Embase, CNKI, and Wanfang Data, covering the period from database inception to August 24, 2023, to identify randomized controlled trials (RCTs). The characteristics and outcomes of the included RCTs were summarized and analyzed, including efficacy indicators by injection site, patient satisfaction, and safety profiles. Network meta-analysis (NMA) was performed using R software to compare efficacy outcomes, including the 6-month improvement response rate for nasolabial folds (NLF) and the global aesthetic improvement scale (GAIS).Results:A total of 38 articles were included. Among them, Juvéderm? was most frequently used as the treatment group (17 out of 38 articles), while Restylane? was the most common comparator (17 out of 38 articles), particularly in studies involving NLF injections (15 out of 16 articles). For collagen stimulators, only 2 studies on Ellansé? were included, both focusing solely on NLF treatment. Quality assessment showed that 34 studies were of medium to high quality, with Juvéderm? accounting for the majority of high-quality studies (11 articles). Based on injection sites, NLF was the most studied area (16 articles), followed by the midface (8 articles), and the remaining 14 articles covered other regions including lips, nose, chin, and infraorbital area. In the NLF region, the 6-month improvement response rate assessed by blinded investigators showed that Juvéderm? showed better outcomes than Restylane? ( RR=1.07, 95% CI: 0.89-1.32), while Belotero? was slightly inferior to Restylane? ( RR=0.97, 95% CI: 0.65-1.44), although the differences were not statistically significant. Subject-reported outcomes showed consistent trends with investigator assessments. For 6-month GAIS improvement, Juvéderm? and Restylane? showed comparable result within the HA filler category ( RR=1.01, 95% CI: 0.71-1.43). The collagen stimulator Ellansé? demonstrated numerically higher values than HA fillers ( RR=1.32, 95% CI: 0.86-2.08). However, none of these differences reached statistical significance. In midface treatments, Juvéderm? had more long-term evidence, with follow-up periods extending up to 24 months. Four studies reported numerically greater volume enhancement with Juvéderm? compared to Restylane?. For other facial areas, Juvéderm? had the most comprehensive clinical evidence, covering the widest range of injection sites. No relevant RCTs were available for collagen stimulators in these regions. Regarding patient satisfaction, 19 studies reported patient-reported outcomes, with Juvéderm? contributing 16 of them, and showing higher satisfaction in 6 head-to-head comparisons with Restylane?. In contrast, collagen stimulators currently lack such evidence. Safety result indicated that HA fillers were generally safe and well tolerated, while safety data for collagen stimulators remain limited due to insufficient high-quality evidence. Conclusion:Among the HA fillers, Juvéderm? has a large quantity and highest quality of clinical studies, and NMA result shows its superior efficacy in NLF. In comparison, the current evidence is still not sufficient to draw a clear conclusion for the PCL/PLLA due to a lack of adequate high-quality clinical evidence regarding its clinical efficacy, PROs, and safety.

Objective To develop a Discharge Readiness Scale for Patients with PICC and to test its reliability and validity.Methods Based on the Meleis transition theory,the initial version of the scale was formed through literature review,qualitative interview,expert enquiry and pre-investigation.Patients with PICC in 2 tertiary hospital in Hangzhou from December 2023 to March 2024 were selected to investigate the reliability and validity of the scale by convenience sampling.Results 352 questionnaires were distributed,and 340 valid questionnaires were recovered,and the validity recovery rate was 96.59％.The exploratory factor analysis extracted 4 common factors with the cumulative variance contribution rate of 80.568％.The confirmatory factor analysis showed that all evaluation indicators of the scale were within ideal standards.The item-level content validity index ranged from 0.79 to 1.00,and the scale-level content validity index was 0.96.The total Cronbach's α coefficient of the scale was 0.963,and the split-half reliability coefficient was 0.889.The Chinese version of the Discharge Readiness Scale was used as a calibration tool,and the correlation coefficients between the total score of the scale and the scores of each dimension and the calibration tool were 0.788 and 0.567～0.878,respectively(all P＜0.05).The Discharge Readiness Scale for Patients with PICC included 26 items in 4 dimensions including physiological and psychological status,knowledge of catheter maintenance,catheter maintenance capability and social support.Conclusion The Discharge Readiness Scale for Patients with PICC has good reliability and validity,and can be used to evaluate the level of discharge readiness among patients with PICC.

BACKGROUND:The progression of chronic oral diseases is closely related to the continuous inflammatory response.Anti-inflammatory peptides are expected to become a substitute for traditional anti-inflammatory drugs due to their rich sources,easy absorption by the body and low side effects.OBJECTIVE:To review the types,anti-inflammatory mechanisms,and their application in oral related diseases.METHODS:CNKI,PubMed,and Web of Science were retrieved,with"polypeptide,anti-inflammatory,immunomodulation,oral inflammatory diseases"as Chinese and English search terms.111 articles related to the classification of anti-inflammatory peptides,anti-inflammatory mechanisms,and application of oral inflammatory diseases were selected for review.RESULTS AND CONCLUSION:(1)Anti-inflammatory peptides are abundant in nature,which can be extracted from plants,animals,and microorganisms.In addition to naturally occurring peptides and protein hydrolysates,peptides synthesized by chemical modification,computer simulation design,and genetic recombination technology can also exert anti-inflammatory effects.The composition,position,and properties of amino acids affect their anti-inflammatory activity.(2)Because the anti-inflammatory mechanism of anti-inflammatory peptides is still unclear,the activity verification is mostly cell experiments,and there is a lack of animal models,clinical trials and other further studies.(3)In the treatment of oral inflammatory diseases(including periodontitis,oral mucositis,caries,pulpitis,suppurative osteomyelitis of the jaw,and peri-implantitis),anti-inflammatory peptides can inhibit the release of inflammatory factors such as interleukin 6,interleukin 1β,and tumor necrosis factor α in oral tissues,regulate inflammatory responses,improve the chronic inflammatory environment,reduce tissue destruction and structural loss,and promote bone tissue regeneration,providing new ideas for the treatment of oral inflammatory diseases.

To evaluate the immunogenicity and immunoprotective effects of a tRNA thiouridylase TgMnmA deletion strain of Toxoplasma gondii(T.gondii)on ICR mice,we constructed a mouse model immunized with RH△MnmA.Mice were immunized with 10 RH△MnmA tachyzoites by in-traperitoneal injection.After 30 d,indirect ELISA was used to detect the specific IgG antibody and its subtypes of immunized mice.Spleen lymphocyte suspension was prepared,and the splenic lym-phocyte subsets were analyzed by flow cytometry.Moreover,the relative expression level of cyto-kine mRNA was detected by real-time fluorescence quantitative PCR.After 30 d of immunization,mice were intraperitoneally inoculated with RH△ku80 tachyzoites.At 5 d post infection,the para-site load in the ascites,heart,liver and brain of mice was measured,and the survival of mice within 30 d after infection was observed and recorded.The results showed that compared with the control PBS group,RH△MnmA immunized group produced higher level of IgG and IgG2a antibodies,higher mRNA relative expression level of cytokines IL-2,IL-4,IL-6,IL-10,IL-12 and IFN-γ,and the number of CD4+and CD8a+in spleen lymphocytes also increased significantly.Mean-while,for the attack of RH△ku80 strain,the immune group can effectively reduce the parasite load in the ascites and some tissues,inhibit the reproduction of parasites In vivo,and significantly improve the survival rate of mice.The results of this study showed that the TgMnmA deletion strain of T.gondii can induce strong humoral and cellular immune responses in mice,and provide good immune protection against the infection of RHΔku80 strain,which has the potential to be-come a potentially promising live attenuated vaccine candidate against T.gondii.

BACKGROUND:The progression of chronic oral diseases is closely related to the continuous inflammatory response.Anti-inflammatory peptides are expected to become a substitute for traditional anti-inflammatory drugs due to their rich sources,easy absorption by the body and low side effects.OBJECTIVE:To review the types,anti-inflammatory mechanisms,and their application in oral related diseases.METHODS:CNKI,PubMed,and Web of Science were retrieved,with"polypeptide,anti-inflammatory,immunomodulation,oral inflammatory diseases"as Chinese and English search terms.111 articles related to the classification of anti-inflammatory peptides,anti-inflammatory mechanisms,and application of oral inflammatory diseases were selected for review.RESULTS AND CONCLUSION:(1)Anti-inflammatory peptides are abundant in nature,which can be extracted from plants,animals,and microorganisms.In addition to naturally occurring peptides and protein hydrolysates,peptides synthesized by chemical modification,computer simulation design,and genetic recombination technology can also exert anti-inflammatory effects.The composition,position,and properties of amino acids affect their anti-inflammatory activity.(2)Because the anti-inflammatory mechanism of anti-inflammatory peptides is still unclear,the activity verification is mostly cell experiments,and there is a lack of animal models,clinical trials and other further studies.(3)In the treatment of oral inflammatory diseases(including periodontitis,oral mucositis,caries,pulpitis,suppurative osteomyelitis of the jaw,and peri-implantitis),anti-inflammatory peptides can inhibit the release of inflammatory factors such as interleukin 6,interleukin 1β,and tumor necrosis factor α in oral tissues,regulate inflammatory responses,improve the chronic inflammatory environment,reduce tissue destruction and structural loss,and promote bone tissue regeneration,providing new ideas for the treatment of oral inflammatory diseases.

To evaluate the immunogenicity and immunoprotective effects of a tRNA thiouridylase TgMnmA deletion strain of Toxoplasma gondii(T.gondii)on ICR mice,we constructed a mouse model immunized with RH△MnmA.Mice were immunized with 10 RH△MnmA tachyzoites by in-traperitoneal injection.After 30 d,indirect ELISA was used to detect the specific IgG antibody and its subtypes of immunized mice.Spleen lymphocyte suspension was prepared,and the splenic lym-phocyte subsets were analyzed by flow cytometry.Moreover,the relative expression level of cyto-kine mRNA was detected by real-time fluorescence quantitative PCR.After 30 d of immunization,mice were intraperitoneally inoculated with RH△ku80 tachyzoites.At 5 d post infection,the para-site load in the ascites,heart,liver and brain of mice was measured,and the survival of mice within 30 d after infection was observed and recorded.The results showed that compared with the control PBS group,RH△MnmA immunized group produced higher level of IgG and IgG2a antibodies,higher mRNA relative expression level of cytokines IL-2,IL-4,IL-6,IL-10,IL-12 and IFN-γ,and the number of CD4+and CD8a+in spleen lymphocytes also increased significantly.Mean-while,for the attack of RH△ku80 strain,the immune group can effectively reduce the parasite load in the ascites and some tissues,inhibit the reproduction of parasites In vivo,and significantly improve the survival rate of mice.The results of this study showed that the TgMnmA deletion strain of T.gondii can induce strong humoral and cellular immune responses in mice,and provide good immune protection against the infection of RHΔku80 strain,which has the potential to be-come a potentially promising live attenuated vaccine candidate against T.gondii.

Objectives:To evaluate the biomechanics of a new self-developed bidirectional self-locking fusion device in vitro.Methods:12 fresh L3/4 segment specimens of domestic pig spine were randomly divided into 3 groups for modeling:normal group(intact state),traditional fusion device group(traditional fusion device and unilateral screw fixation)and new fusion device group(bidirectional self-locking fusion device implanted).On the basis of MTS multi-freedom(spinal motion)simulation test system and 500N preload,8N·m load was applied to experimental specimens in each direction successively,and the stability test was carried out according to the order of forward bending,backward extension,left bending,right bending,and left and right rotation.The ranges of motion(ROMs)were compared between groups under different working conditions.The axial fatigue compression test was carried out with TT-JQ-01-106 fatigue testing machine to evaluate the stability and reliability of the self-developed fusion device.Results:Compared with the normal group,the ROM of the new fusion device group was significantly decreased under the conditions of flexion(1.67°±0.65° vs 3.46°±0.16°),extension(1.43°±1.01° vs 1.89°±0.29°),left bending(2.07°±1.32° vs 3.08°±0.09°),right bending(1.38°±0.72° vs 4.37°±0.20°),and right rotation(2.17°±1.51° vs 5.10°±0.37°)(all P＜0.05);Under the left rotation condition,the ROM value(3.10°±1.57°)of the new device group was significantly higher than that of the normal group(2.36°±0.62°)(P＜0.05).Compared with the conventional fusion device group,the ROM of the new fusion device group was significantly increased under flexion(1.67°±0.65° vs 1.22°±0.76°)and left rotation(3.10°±1.57° vs 1.57°±0.91°)conditions(P＜0.05);However,there were no significant differences in ROMs between the two groups under extension(1.43°±1.01° vs 1.06°±0.50°),left bending(2.07°±1.32° vs 1.87°±1.41°),right bending(1.38°±0.72° vs 1.45°±0.69°),and right rotation(2.17°±1.51° vs 1.69°±1.07°)conditions(P＞0.05).The ROM values of the normal group under flexion,extension,left bending,right bending,and right rotation conditions were significantly higher than those of the other two groups(P＜0.05).Fatigue test:after 5 million load-displacement cycles,visual inspection revealed no deformation or cracks in the fusion device,and the axial compression fatigue test was passed.Conclusions:The bidirectional self-locking fusion device can obviously improve the stability of the fusion segment,which is equivalent to the stability of using the posterior single-sided nail rod system,meanwhile,it has good fatigue resistance,therefore its mechanical properties can meet the needs of clinical applications.